Current perspective of neuroprotection and glaucoma
Kailin Tian,1,2 Shannon Shibata-Germanos,1 Milena Pahlitzsch,1 M Francesca Cordeiro1,3 1Glaucoma and Retinal Neurodegeneration Research Group, UCL Institute of Ophthalmology, London, UK; 2Eye Centre, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 3Western Eye Hosp...
Enregistré dans:
Auteurs principaux: | Tian K, Shibata-Germanos S, Pahlitzsch M, Cordeiro MF |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a488c007d52545829d538b4a1b41dc62 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
par: Anna Galanopoulos, et autres
Publié: (2008) -
Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma
par: Pahlitzsch M, et autres
Publié: (2015) -
Current perspectives on ranibizumab
par: Dedania VS, et autres
Publié: (2015) -
Keratoconus: current perspectives
par: Vazirani J, et autres
Publié: (2013) -
Current primary open-angle glaucoma treatments and future directions
par: Beidoe G, et autres
Publié: (2012)